Radiofrequency Ablation Devices Market by Top Manufacturers – Halyard Health, Inc., Stryker Corporation, St. Jude Medical, Inc., Medtronic Plc, Boston Scientific Corporation, C. R. Bard, Inc., AngioDynamics

Radiofrequency ablation (RFA) is a medical process in which a dysfunctional tissue is ablated using the heat generated by high-frequency electromagnetic waves. Advantages of using radiofrequency current for ablation are that there is no need for general anesthetics as the nerves or muscles are not directly stimulated and the treatment is very specific to the desired tissue, without causing any significant collateral damage. It is a minimally invasive procedure that is utilized in various fields of medicine such as pain management, cardiac rhythm management, oncology, and renal denervation for hypertension. RFA helps to shrink and destroy the tumor cells. In pain management, it is used to reduce pain by heat destruction of nerves that conduct nerve impulses.

Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/22952?utm_source=OPR&utm_medium=Anil

The world radiofrequency ablation devices market was valued at $1,729.7 million in 2015 and shall grow at a CAGR of 11.8% to reach $3,785.3 million by 2022. This is attributed to the increase in demand for minimally invasive surgeries, rise in prevalence of cancer, high efficacy, and short duration of the procedure. The rise in the incidence of patients with chronic pain due to the increase in prevalence of obesity, diabetes, osteoarthritis, cancer, and rheumatoid arthritis also contributed towards the growth of the RFAD market. However, the cost associated with this technology and lack of awareness among patients hinders the market growth.

The world RFAD market is segmented into three categories: application, product type, and geography. Based on the type of application, the market is bifurcated into oncology, pain management and cardiology. Based on product type, it is divided into devices, and disposables. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players in the RFAD market. On August 3, 2016, Boston Scientific Corporation completed the acquisition of Cosman Medical, which helped it to improve its product portfolio of non-opioid solutions for chronic pain. On August 7, 2016, St. Jude Medical, Inc. acquired NeuroTherm, Inc., which is expected to accelerate the growth of St. Jude Medical’s business in chronic pain and strengthen its position as a global leader in developing therapies for chronic pain treatment.

KEY MARKET BENEFITS:
• The world radiofrequency ablation devices market report provides an extensive analysis of the current market trends and future estimations through 2014‐2022.
• The market scenario is comprehensively analyzed with respect to the application and product type.
• Comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities.
• Recent developments and key manufacturers are listed to understand the competitive market scenario.
• In-depth analysis based on geography provides an understanding of the regional market, which assists in strategic business planning.

The key players profiled in this report are listed below: Halyard Health, Inc., Stryker Corporation, St. Jude Medical, Inc., Medtronic Plc, Boston Scientific Corporation, C. R. Bard, Inc., AngioDynamics, Inc., Hologic, Inc., AtriCure, Inc., Johnson & Johnson, Baylis Medical, Arthrex, Inc., inomed Medizintechnik GmbH, Sutter Medizintechnik GmbH, Bramsys Indústria e Comércio Ltda, ENDO-FLEX GmbH, Epimed International, sfm medical devices GmbH

Get a discount on this research report @ https://www.bigmarketresearch.com/request-for-discount/22952?utm_source=OPR&utm_medium=Anil

Table of Content:
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO Perspective
2.2 Market beyond: what to expect by 2027 ($million)
2.2.1 Moderate Growth Scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Government regulations
3.3.1 U.S. FDA
3.3.2 Europe CE Mark
3.3.3 Ministry of Health, Labour and Welfare (MHLW)
3.4 Reimbursement scenarios
3.5 Porter's five forces analysis
3.5.1 Low bargaining power of suppliers
3.5.2 Moderate bargaining power of buyers
3.5.3 Low threat of new entrants
3.5.4 Low threat of substitutes
3.5.5 Moderate competitive rivalry
3.6 Clinical trials
3.7 Patent analysis
3.7.1 China: Patent Analysis by Market Participants
3.7.2 The U.S.: Patent Analysis by Market Participants
3.7.3 Europe: patent analysis, by market participant
3.7.4 Canada: patent analysis, by market participant
3.7.5 Others: Patent Analysis, by Market Participant
3.8 Top player positioning, 2015
3.9 Top impacting factors
3.9.1 Drivers
3.9.1.1 Rise in the prevalence of cancer and cardiac diseases
3.9.1.2 Increase in the number of patients suffering from pain
3.9.1.3 High efficacy and short duration of the procedure
3.9.2 Restrains
3.9.2.1 High cost of treatment
3.9.2.2 Limited awareness
3.9.2.3 Availability of other treatments
3.9.3 Opportunities
3.9.3.1 Lucrative opportunities in emerging markets
3.9.3.2 Untapped RFA market opportunity
3.9.3.3 Recent advancements
CHAPTER 4 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Cardiology
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Irrigated-tip RF ablation catheters
4.2.5 Conventional RF ablation catheters
4.3 Oncology
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Breast cancer
4.3.5 Colorectal cancer
4.3.6 Lung cancer
4.3.7 Prostate cancer
4.3.8 Liver cancer
4.3.9 Kidney cancer
4.3.10 Spinal metastases
4.3.11 Other cancers
4.4 Pain management
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Neck pain
4.4.5 Shoulder pain
4.4.6 Upper back pain
4.4.7 Lower back pain
4.4.8 Knee pain
4.4.9 Other pain syndromes

Inquiry before Buy @ https://www.bigmarketresearch.com/purchase-enquiry/22952?utm_source=OPR&utm_medium=Anil

About Us:
Industry executives tend to keep a tab on their business competitors. This keeps them updated on strategic business activities and investment trends. Company profiles are crucial to participating players of interconnected verticals.

5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
Call answer Direct: +1-971-202-1575
Call answer Toll Free: +1-800-910-6452
Email help@bigmarketresearch.com

This release was published on openPR.